Hodgkin's Disease by Scarffe, J. H.
458 BOOK REVIEWS
selected group at high risk who should be
screened.
The book provides a very compact
description ofthe many factors of importance
both in the development of breast cancer and
in its prognosis. With its extensive list of
references, it will be of value to workers in
this field.
M. P. COLE
Hodgkin'sDisease.Ed.MORTIMERJ.LACHER
(1976). New York: John Wiley & Sons.
429 pp. Price £14.00 net.
The management of patients with Hodg-
kin's disease has changed a great deal over
the last decade, with the introduction of
staging laparotomies, improved radiotherapy
techniques and effective combination chemo-
therapy. This book aims, in a series of
chapters written by a variety of American
authorities, to bring together the vast
literature thathasaccumulated recently about
this rare disease. It divides conveniently
into three main sections: staging, treatment
and complications of Hodgkin's disease.
The chapters onthe accurate staging ofthe
disease are informative and well illustrated.
The indications and surgical technique
for staging laparotomy and splenectomy
are covered in detail. Dr Lacher finishes the
section by hoping that in the not so distant
future the laparotomy/splenectomy procedure
" will eventually be recalled only as a mile-
stone in the history of Hodgkin's disease and
management, important at the time, but
abandoned because it was no longer needed ".
The section on treatment is not as clear
and informative as the other parts ofthebook.
The radiotherapy techniques employed at the
Memorial Hospital are described in detail, but
these are new techniques with few results.
A book ofthis nature requires an authoritative
review chapter on the use of radiotherapy in
Hodgkin's disease, with long-term results of
various techniques and doses. The chemo-
therapy section overlaps in a number of
chapters, and is based mainly on American
results. British oncologists will be dis-
appointed to see the results of the MVPP
regime (introduced by the late Professor G. H.
Fairley) reported as giving only a 420
complete remission rate, approximately half
of the actual remission rate.
The chapters on neurological complica-
tions, infections, respiratoryfailureandgastro-
intestinal manifestations are all comprehen-
sive and valuable reading. A short chapter
on the use of Indomethacin for controlling
fever in Hodgkin's disease is an added bonus,
as is the chapter on "Clinical Vignettes" from
Dr Lacher's wide experience.
There is much to interest any doctor who
comes into contact with patients suffering
from Hodgkin's disease, whether he be
surgeon, radiotherapist, chemotherapist,
general practitioner or physician. It joins
the books on the subject edited by Kaplin
and Smithers as compulsory reading for any
doctor specializing in the management of
Hodgkin's disease.
J. H. SCARFFE
Unclassifiable Leukaemias. Proceedings
of a Symposium, October 11-13th 1974 at
the Institute of Cell Pathology, Hopital
de Bicetre, Paris. Ed. M. BESSIS and
G. BRECHER (1976). Berlin: Springer-
Verlag. 270 pp. Price $19.70 net.
Any haematologist who deals with leukae-
mic material knows that a significant
minority of patients with clinically " acute "
disease have blood and marrow pictures
which are not readily classifiable by morpho-
logical criteria alone. This symposium, to
which many distinguished clinical and experi-
mental workers contributed, was an attempt
to correlate " empirical " cytology and cyto-
chemical methods with other characteristics
of the leukaemic cell, such as immunological
markers, cytogenetics, electron microscopy,
cultural patterns and cell kinetics.
The book opens with an account of the
undoubted limits ofthe present morphological
classification ofacute leukaemias by Flandrin
and Bernard wNho nevertheless, surprisingly,
found that only 2%0o of 1409 cases seen in their
clinic were eventually labelled " undifferenti-
ated leukaemia ". Galton and Dacie give a
detailed analysis of material admitted to the
4th and 5th MRC trials on acute myeloblastic
leukaemia. Some British haematologists
have found it difficult to comprehend the sub-
classification ofALL given by Mathe, though
most now recognise the microlymphoblastic
and immunoblastic types; it is interesting
that this classification includes prolympho-
cytic leukaemia as a variant of ALL and not
CLL, as is sometimes assumed.